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Refractory or recurrent episodes of sustained ventricular
tachycardia are a potentially life-threatening complication of
acute myocardial infarction and of various forms of car-
diomyopathy. In either setting, increased ventricular wall ten-
sion may exacerbate acute or chronic ischemia and the resul-
tant milieu can lead to sudden death. Mechanical circulatory
assistance is effective in improving survival for patients with
overt pump failure, as a “bridge to transplantation.” On the
basis of recent reports, modern implantable systems may also
be effective in extinguishing ventricular arrhythmias and suc-
cessfully bridging such patients to transplantation.1 We report
a case of an acute postoperative myocardial infarction and
medically refractory ventricular tachycardia in which inser-
tion of a left ventricular assist device (LVAD) successfully
extinguished the arrhythmia and allowed the patient to recov-
er satisfactorily without transplantation.
Clinical summary. A 41-year-old man with normal ven-
tricular function was referred for coronary artery bypass
grafting. He underwent uneventful bypass grafting of the left
anterior descending coronary artery and the obtuse marginal
branch. Thirty minutes later, he had acute vein graft occlusion
and signs of acute ischemia in the lateral precordial leads. He
was returned to the operating room immediately for revision
of the circumflex graft. No technical problem was identified,
but the graft was redone. The patient was found subsequent-
ly to have a hypercoagulable state, characterized by inherited
protein-S deficiency and hyperreactive platelets, even while
he was receiving aspirin (Sonoclot; HEMEX LABS,
Phoenix, Ariz).
He had several episodes of sustained and medically refrac-
tory ventricular tachycardia associated with complete circu-
latory collapse. Ventricular countershocks and treatment with
high-dose magnesium sulfate and intravenous amiodarone
terminated each episode, and the patient remained in neuro-
logically intact condition. During periods of sinus rhythm,
hemodynamics were satisfactory (cardiac index > 2.5 L/min
per square meter) on minimal doses of inotropic agents. The
electrocardiogram did not show a recurrence of changes sug-
gesting reocclusion of the graft. The third overt cardiac arrest,
which was more difficult to terminate, prompted the initiation
of left ventricular support with the ABIOMED BVS-5000
LVAD (Abiomed, Inc, Danvers, Mass). LVAD flows were
approximately 4.5 L/min and bleeding after insertion was
minimal. Ventricular tachycardia was completely extin-
guished and premature ventricular complexes all but disap-
peared. He awoke 12 hours after the operation in neurologi-
cally intact condition.
Multiorgan system dysfunction resolved over the next 2
weeks. He was able to ambulate in his room while being sup-
ported by the LVAD, but on support day 22 moderately severe
left hemiparesis developed, and he required an additional 9
days of mechanical ventilatory support because of adult res-
piratory distress syndrome. The neurologic deficit slowly
resolved and support was discontinued after 27 days with no
recurrence of ventricular tachycardia and no signs or symp-
toms of cardiac failure. A follow-up echocardiogram showed
a left ventricular ejection fraction of 45% to 50%. In addition,
4 months later he was able to ambulate with a cane and per-
form activities of daily living.
Discussion. In this report, we describe a situation in which
LVAD insertion was prompted by recurrent ventricular tachy-
cardia and resultant circulatory collapse in a patient without
evidence of overt left ventricular pump failure. The arrhyth-
mia was completely eradicated, and we are aware of no sim-
ilar, previously reported case of “bridging to recovery” in the
postcardiotomy setting. Medical therapy was ineffective and
no evidence of active, correctable ischemia was present.
Satisfactory ventricular unloading and circulatory support
circumvented the threat of sudden death and was lifesaving.
The infarction-related irritable focus was given an opportuni-
ty to heal. We also realize that direct apical cannulation, cho-
sen to maximize drainage, may have obliterated the focus and
eradicated the arrhythmia. In either case, our experience rep-
resents an expanded application of intermediate-term LVAD
support.
Early LVADs were inserted into patients with profound cir-
culatory failure and were intended for brief periods of sup-
port in the postcardiotomy setting. The recent experience
with advanced, but prototypical, long-term implantable
LVADs has shown their efficacy in improving end-organ
function and survival in patients in the “bridge-to-transplan-
tation” setting.2 The organization of the REMATCH trial, a
Food and Drug Administration–approved study of mechani-
cal support as “destination therapy,”3 and the Berlin experi-
ence4 suggest that the indications for the insertion of such
systems have expanded. The report by Muller and associates4
suggests that some patients with end-stage cardiomyopathy
may be bridged to recovery. Acceptance of this idea requires
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a conceptual paradigm shift from that of the early implemen-
tation of temporary, centrifugal, short-term support devices.
The concept of “destination” or permanent therapy, rather
than insertion with the intention of “bridging to transplanta-
tion,” could be viewed as a maturation or evolution of the use
of these devices. This evolution is a result of advances in
technology, experience, and surgical expertise. However, the
German report, in particular,4 brings to light the increasingly
widespread realization that mechanical unloading of the fail-
ing, ischemic, or stunned ventricle for a variable length of
time may lead to recovery of the heart.5 Similarly, our report
suggests that patients with acute, infarction-related refractory
arrhythmias and concomitant circulatory collapse may bene-
fit from intermediate-term ventricular unloading and circula-
tory support, even in the absence of overt pump failure. This
case, in particular, illustrates the way in which such support,
when implemented in a timely fashion, may avert life-threat-
ening multiorgan system failure. We believe this experience
demonstrates the benefit of an aggressive surgical posture and
a commitment to vigilance with respect to the early initiation
of support in an expanded patient population.
We acknowledge the assistance of the cardiac surgery ser-
vice, University Medical Center, Tucson, Arizona, in caring
for this patient.
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